Market leadership PANTHERx Rare is the largest independent rare pharmacy in the U.S. with a track record of national licensing across all 50 states and multiple prestigious accreditations, signaling strong credibility when engaging potential pharmaceutical partners and patient access programs.

Strategic partnerships Recent client signings with Rhythm Pharmaceuticals and Savara position PANTHERx as the exclusive U.S. specialty pharmacy for expanded indications, presenting opportunities to upsell expanded therapy coverage and bundled patient support services to similar rare-disease manufacturers.

Award driven credibility Multiple MMIT Patient Choice Awards and leadership recognition for the CEO enhance trust with payers, life sciences companies, and provider networks, enabling faster stakeholder buy-in for new patient access initiatives and channel partnerships.

Operational scale with agility Large revenue scale combined with a small-company feel suggests capacity to scale support programs quickly while maintaining high-touch patient care, making PANTHERx an attractive partner for manufacturers seeking robust patient navigation, adherence programs, and prescriber engagement.

Technology enabled Adoption of modern tech stack including REST, Tableau, Azure SQL, NoSQL, and cloud-based security demonstrates a data-driven approach to patient access and outcomes, offering opportunities to co-develop advanced analytics, reporting, and real-time performance dashboards for clients.